New Delhi February 17, 2014:- The Pune Regional Office of IARI has come out with a virus-resistant papaya variety that has the potential to revolutionize the papaya industry the world over. This is a transgenic variety.
This institute has done significant work in the control of plant viruses and has developed virus resistant varieties of many fruits and vegetables. It has also developed production strategies for managing virus diseases in a large number of crops. Virus diseases lead to large-scale losses in many important horticultural crops such as papaya, citrus fruits, capsicum, tomato and cucurbits.
Agriculture Minister, Shri SharadPawar, today inaugurated the new building of this institute. On this occasion, Shri Pawar expressed the hope that the new infrastructure being set up would help the institute to utilize the most modern technology in control of plant diseases. This new facility would also help state agricultural universities and sister institutes of the ICAR in Maharashtra, he said.
Shri Pawar informed that this institute started way back in 1938 as the first research centre on plant virology and has done pioneering research in the control of plant viruses. The Department of Biotechnology has recognized it as an ‘accredited test laboratory, under its National Certification System.
The institute’s Pune Selection -3 papaya variety gives an average yield of 40 tonnes per hectare even under high disease pressure. It recently signed MoU with a biotech company for production of virus-free tissue culture raised banana seedlings. This, Shri Pawarexpects, will ensure high returns to farmers.
Pearson Syndrome is an extremely rare condition and the prevalence is approximately 1 in a…
A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…
People who smoke are also at much higher risk of developing diabetes compared to non-smokers…
17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…
Lonavala, November 12, 2024: As the global cancer burden rises to 30 million cases by…
The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…